Navigation Links
Star Scientific Receives a Warning Letter From the FDA Regarding Consumer Products
Date:12/31/2013

GLEN ALLEN, Va., Dec. 31, 2013 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) announced the receipt on December 24, 2013, of a warning letter from the U.S. Food and Drug Administration (FDA) regarding two consumer products, Anatabloc® and CigRx®, which are marketed by the Company.  The letter requires the Company to respond to the FDA with information and remedial steps.

(Logo: http://photos.prnewswire.com/prnh/20130319/PH79245LOGO )

Both of the Company's consumer products contain anatabine, a substance naturally occurring in various plants. In the letter, the agency asserts that anatabine is a new dietary ingredient that required premarket notification to the agency. The agency also asserts that the Company's products are unapproved new drugs based on statements made on the Company's websites.  As is typical for warning letters issued by FDA, the agency stated that the Company's failure to address these alleged violations may result in regulatory action by the FDA without further notice.  The Company is responding to the letter and has already advised the agency that it intends to work cooperatively to resolve these issues, including undertaking a review of the Company's websites.  

Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may
'/>"/>

SOURCE Star Scientific, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Donald Fresne, President and CEO of Egenix, Inc. is pleased to announce the appointment of Adrian Schwarzer, MD, Ph.D. to its Scientific Advisory Committee
2. Cole-Parmer Introduces Innovative Laboratory Instruments from VELP Scientifica
3. Scientific Research and Development in the US Industry Market Research Report from IBISWorld Has Been Updated
4. Enteris BioPharma Forms Scientific Advisory Board to Enhance Leadership in Oral Delivery of Peptide and Small Molecule Drugs
5. How to Enhance Scientific Intuition in Pharmaceutical R&D: the CBCD Highlights a Revolutionary New Technology
6. ImaginAb Expands Scientific Advisory Board
7. Regenerons Chief Executive Officer and Chief Scientific Officer named "Management Team of the Year" by Scrip Intelligence
8. CMDBioscience Appoints Tomi Sawyer to Scientific Advisory Board; Entrepreneurial Drug Hunter and Distinguished Scholar Named as Founding Chair
9. Hamilton Scientific Products Installed at Wisconsin Energy Institute & Consolidated Forensic Lab, University of Wisconsin
10. Amgen to Highlight New Evolocumab (AMG 145) Data at Upcoming American Heart Association Scientific Sessions 2013
11. Sensible Medical Innovations Closes on Financing Round Led by Boston Scientific Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... MESA, Calif. , July 24, 2014  Now ... close to home. Rehealth Regenerative Therapies , located ... athletes and other physically active people a new health ... Regardless of age, countless patients suffer from ... sport activities, such as muscle tears, torn rotator cuff, ...
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 ... biotechnology company in the emerging field of regenerative ... live webcast of a presentation to investors on ... 1:30 p.m. PDT.  The presentation will include an ... pipeline. To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... , July 24, 2014  ECC West Africa, LLC ... with University College Hospital (UCH) Ibadan Board ... project to finance, design, construct, and operate and maintain ... Nigeria . Under the first of the 4-phase ... documents and funding applications. UCH Ibadan intends to finance ...
(Date:7/24/2014)... sophisticated equipment, trained personnel, and detection dogs to ... attacks. A revolutionary new electronic chip with nano-sized ... much easier. , The groundbreaking nanotechnology-inspired sensor, devised ... ,s School of Chemistry and Center for Nanoscience ... Tracense, picks up the scent of explosives molecules ...
Breaking Biology Technology:Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2Nano-sized chip 'sniffs out' explosives far better than trained dogs 2
... 2008 at 9:30 a.m., SUNRISE, Fla., Aug. 1 ... Leonhardt, Chairman and CEO of,Bioheart, will present a corporate ... the Red Chip Investor Conference at the Marriott,Marquis in ... will be,available via the internet by visiting and registering ...
... Monitoring and ... Diagnostic System, ... ), announced it has entered into a non-binding letter of,intent ... a real-time wireless beat-to-beat, intelligent heart monitor and,diagnostic system, designed ...
... Holdings, a newly-formed,holding company that is the parent ... Diagnostics (CMDx), announced today that George Poste,D.V.M., Ph.D, ... with,the company, serving as Non-Executive Vice Chairman and ... of CMDx. Dr. Poste has,been a Director of ...
Cached Biology Technology:Bioheart, Inc. to Present at Red Chip Investor Conference in New York 2Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 2Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 3Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 4Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd. 5Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics 2Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics 3
(Date:7/24/2014)... , July 24, 2014 /PRNewswire-iReach/ -- The Geneva Healthcare ... cardiac devices, has cut emergency room wait times by ... Diego (UCSD) Medical Center, according to a recent study ... Emergency Departments are using the suite to access data ... or defibrillators. "Using Geneva,s technology platform we ...
(Date:7/24/2014)... (July 24, 2014) Scientists at The New ... one step closer to creating a viable cell ... own cells. , For the first time, ... lines from skin samples of patients with primary ... accelerated protocol to induce these stem cells into ...
(Date:7/24/2014)... animal species for food or commercial food sale, has ... the decline of many species of primates and other ... than half of the species being consumed are birds, ... not only the meat made available for sale but ... by hunters and brought to villages for consumption, we ...
Breaking Biology News(10 mins):UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... Delhi, IndiaThe Government of India,s Department of Biotechnology (DBT) ... III clinical trial of a rotavirus vaccine developed and ... at the International Symposium on Rotavirus Vaccines for IndiaThe ... excellent safety and efficacy profile. The clinical ...
... China, Australia and Japan today reports having sequenced and annotated ... have a powerful genetic system that repairs genetic defects, and ... than 86 percent of the nearly 27,000 genes of the ... and elsewhere as a symbol of spiritual purity and longevity. ...
... Ohio A study has identified microRNA-155 as a ... with acute myeloid leukemia that has normal-looking chromosomes under ... or CN-AML)., The study was led by researchers at ... G. James Cancer Hospital and Richard J. Solove Research ...
Cached Biology News:Rotavirus vaccine developed in India demonstrates strong efficacy 2Rotavirus vaccine developed in India demonstrates strong efficacy 3Rotavirus vaccine developed in India demonstrates strong efficacy 4Scientists sequence genome of 'sacred lotus,' which likely holds anti-aging secrets 2Scientists sequence genome of 'sacred lotus,' which likely holds anti-aging secrets 3Scientists sequence genome of 'sacred lotus,' which likely holds anti-aging secrets 4Study identifies possible new acute leukemia marker, treatment target 2